BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23404707)

  • 1. Host-rabies virus protein-protein interactions as druggable antiviral targets.
    Lingappa UF; Wu X; Macieik A; Yu SF; Atuegbu A; Corpuz M; Francis J; Nichols C; Calayag A; Shi H; Ellison JA; Harrell EK; Asundi V; Lingappa JR; Prasad MD; Lipkin WI; Dey D; Hurt CR; Lingappa VR; Hansen WJ; Rupprecht CE
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E861-8. PubMed ID: 23404707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsid assembly as a point of intervention for novel anti-viral therapeutics.
    Lingappa VR; Hurt CR; Garvey E
    Curr Pharm Biotechnol; 2013; 14(5):513-23. PubMed ID: 22429134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor.
    Lingappa JR; Lingappa VR; Reed JC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.
    Reed JC; Solas D; Kitaygorodskyy A; Freeman B; Ressler DTB; Phuong DJ; Swain JV; Matlack K; Hurt CR; Lingappa VR; Lingappa JR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex.
    Michon M; Müller-Schiffmann A; Lingappa AF; Yu SF; Du L; Deiter F; Broce S; Mallesh S; Crabtree J; Lingappa UF; Macieik A; Müller L; Ostermann PN; Andrée M; Adams O; Schaal H; Hogan RJ; Tripp RA; Appaiah U; Anand SK; Campi TW; Ford MJ; Reed JC; Lin J; Akintunde O; Copeland K; Nichols C; Petrouski E; Moreira AR; Jiang IT; DeYarman N; Brown I; Lau S; Segal I; Goldsmith D; Hong S; Asundi V; Briggs EM; Phyo NS; Froehlich M; Onisko B; Matlack K; Dey D; Lingappa JR; Prasad DM; Kitaygorodskyy A; Solas D; Boushey H; Greenland J; Pillai S; Lo MK; Montgomery JM; Spiropoulou CF; Korth C; Selvarajah S; Paulvannan K; Lingappa VR
    Open Biol; 2024 Jun; 14(6):230363. PubMed ID: 38889796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.
    Real E; Rain JC; Battaglia V; Jallet C; Perrin P; Tordo N; Chrisment P; D'Alayer J; Legrain P; Jacob Y
    J Virol; 2004 Jul; 78(14):7410-7. PubMed ID: 15220414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly.
    Lingappa JR; Dooher JE; Newman MA; Kiser PK; Klein KC
    J Biol Chem; 2006 Feb; 281(7):3773-84. PubMed ID: 16275648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets.
    Marreiros R; Müller-Schiffmann A; Bader V; Selvarajah S; Dey D; Lingappa VR; Korth C
    Virus Res; 2015 Sep; 207():155-64. PubMed ID: 25451064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acetylcholine receptor alpha 1(nAChRα1) subunit peptides as potential antiviral agents against rabies virus.
    Sajjanar B; Dhusia K; Saxena S; Joshi V; Bisht D; Thakuria D; Manjunathareddy GB; Ramteke PW; Kumar S
    Int J Biol Macromol; 2017 Nov; 104(Pt A):180-188. PubMed ID: 28587964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly.
    Wan JJ; Brown RS; Kielian M
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein.
    Hernáez B; Tarragó T; Giralt E; Escribano JM; Alonso C
    J Virol; 2010 Oct; 84(20):10792-801. PubMed ID: 20686048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
    Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
    Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.
    Orabi A; Bieringer M; Geerlof A; Bruss V
    J Virol; 2015 Sep; 89(18):9281-7. PubMed ID: 26136564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
    Ruan L; Hadden JA; Zlotnick A
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.
    Ludgate L; Liu K; Luckenbaugh L; Streck N; Eng S; Voitenleitner C; Delaney WE; Hu J
    J Virol; 2016 Jun; 90(12):5830-5844. PubMed ID: 27076641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad spectrum compounds targeting early stages of rabies virus (RABV) infection.
    Kali S; Jallet C; Azebi S; Cokelaer T; Da Fonseca JP; Wu Y; Barbier J; Cintrat JC; Gillet D; Tordo N
    Antiviral Res; 2021 Apr; 188():105016. PubMed ID: 33444703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Mumps Virus Replication and Transcription by Kinase RPS6KB1.
    Briggs K; Wang L; Nagashima K; Zengel J; Tripp RA; He B
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.